6978 — Immunotech Biopharm Share News
0.000.00%
Last trade - 00:00- HK$225.39m
- HK$621.13m
Brief: Immunotech Biopharm Receives Notice Of Rejection For Conditional New Drug Application For EAL Dated 27 April 2026
Brief: Trading In Shares Of Immunotech Biopharm Will Be Halted At 1:00 PM On April 28, HKEX Says
Brief: Immunotech Biopharm Posts Loss And Total Comprehensive Expense For Year Attributable Rmb230.8 Million
Brief: Immunotech Biopharm Subscribes To Structured Deposit Product With Investment Value Of RMB50 MLN
Brief: Immunotech Biopharm To Issue Convertible Bonds
Brief: Immunotech Biopharm Says Jiaze Global Capital To Subscribe For New Convertible Bonds, Note
Brief: Immunotech Biopharm Subscribes To Structured Deposit Products From Bank Of China Worth RMB120 Million
Brief: Immunotech Biopharm says Underwriter Agreed To Underwrite Up To 123.1 Million Rights Shares
Brief: HKEX Says Trading In Shares Of Immunotech Biopharm Will Be Halted On Sept 19
Brief: Immunotech Biopharm Says Zhang Jian Appointed As Acting CEO
Brief: Immunotech Biopharm Says Conditional New Drug Application Of EAL Accepted By NMPA
Brief: Immunotech Biopharm's CAR-T-19 Injection Granted Breakthrough-Therapy Designation By NMPA China
Brief: Immunotech Biopharm Posts HY Loss Attributable RMB92.5 Million
Brief: Immunotech Biopharm H1 Pretax Profit RMB -92.6 Million
Brief: Immunotech Biopharm Says Yang Ning Resigned As CFO
Brief: Immunotech Biopharm Disposed Total RMB80.0 Mln Of Certificates Of Deposits
Brief: Immunotech Biopharm Announces Clinical Trial Approval For AT19 Injection
Brief: Immunotech Biopharm Says Got Acceptance Notice For IND Application For AT19 Injection
Brief: Immunotech Biopharm Granted Breakthrough Therapy Designation